Diffractive ultrasound technology developer Advanced Imaging Technologies has received Food and Drug Administration clearance for a breast biopsy capability on its Avera breast imaging system. The biopsy feature will allow physicians to perform immediate biopsies on suspicious breast masses during an imaging session, according to the Preston, WA-based vendor.
By AuntMinnie.com staff writers
May 31, 2002
Related Reading
Advanced Diagnostic changes name, March 28, 2002
New ultrasonic approach focuses on breast imaging, November 27, 2001
Copyright © 2002 AuntMinnie.com